Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prison walls may not stop Animal-Borne diseases

NCT ID NCT07808775

Knowledge-focused Sponsor: Centre Hospitalier de Cayenne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are measuring how often five animal-borne infections appear among inmates at the French Guiana Correctional Facility. The study follows newly arrived adults for up to 12 months, testing for Q fever, leptospirosis, Chagas disease, histoplasmosis, and toxoplasmosis. The team also checks whether local weather patterns and individual factors relate to infection risk. The goal is to document a poorly understood health threat and inform prevention and screening in detention.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study documents how these infections spread in the prison, it could guide screening and prevention measures that improve health conditions for inmates and staff.
What could go wrong
This is an observational study, so it cannot prove what causes infections or that any prevention measure works. Findings from one facility may not apply to other prisons or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 450 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults above 18 years old, incarcerated and housed at the French Guiana Correctional Facility for 15 days or less, from september 2026 to september 2028

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult aged 18 or older * Incarcerated and housed at the French Guiana Correctional Facility for 15 days or less. Exclusion Criteria: * Refusing to participate in the study * Pregnant women * Had already participated in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chagas disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chagas disease histoplasmosis leptospirosis Q fever toxoplasmosis Zoonoses

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chagas disease Histoplasmosis Leptospirosis Q fever Toxoplasmosis infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier de Cayenne

    Cayenne, French Guiana, 97300, French Guiana

More trials for these conditions

Other studies related to the condition(s) this trial covers.